Abstract
Systemic sclerosis (SSc) is associated with a significant reduction in life expectancy. A simple prognostic model to predict 5-year survival in SSc was developed in 1999 in 280 patients, but it has not been validated in other patients. The predictions of a prognostic model are usually less accurate in other patients, especially from other centres or countries. A study was undertaken to validate the prognostic model to predict 5-year survival in SSc in other centres throughout Europe.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Annals of the Rheumatic Diseases |
| Vol/bind | 70 |
| Udgave nummer | 10 |
| Sider (fra-til) | 1788-92 |
| Antal sider | 5 |
| ISSN | 0003-4967 |
| DOI | |
| Status | Udgivet - 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS